This study reports several innovative findings, including the first observation of a seemingly paradoxical immunological phenomenon in which umbilical cord blood IL-17A levels were significantly lower in the perinatal complications (PC) group compared with the NPC group, suggesting that IL-17A exerts immunoprotective effects below a specific threshold. Here, IL17A is linked to nasopharyngeal carcinoma.